Form 4 for TWST Twist Bioscience Corp
Accepted 2026-06-02 16:05:30 ET · period of report 2026-05-29 · accession 0001214659-26-007029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-02 16:05 | 2026-05-29 | TWST | Laponis Adam | CFO | S - Sale | $70.00 | -4,000 | 112.7K | -3% | -$280.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-29 | S | D | 4,000 | $70.00 | 112,675 | D | — | — | (F1) The transaction reported on this Form 4 is effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 8, 2025. |